KRT19, keratin 19, 3880

N. diseases: 270; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0030286
Disease: Pancreatic Diseases
Pancreatic Diseases
0.020 Biomarker group BEFREE In the clinical use, CK-19 is suitable for the distinction between malignant and benign pancreatic disease in combination with other tumor-specific markers. 17226905 2007
CUI: C0030286
Disease: Pancreatic Diseases
Pancreatic Diseases
0.020 AlteredExpression group BEFREE Keratin 19 mRNA expression was studied by RT-PCR in cancer tissues (12 pancreatic and 15 gastric cancers) and in peripheral and/or portal blood samples from patients with pancreatic cancer (stage I, n = 5; stage II, n = 1; stage III, n = 15; stage IV, n = 19), gastric cancer (stage la,b, n = 28; stage II, n = 9; stage IIIa,b, n = 5; stage IVa,b, n = 7) and benign pancreatic diseases (n = 7). 9247282 1997